Interactions Between 2'-fluoro-(carbamoylpyridinyl)deschloroepibatidine Analogues and Acetylcholine-binding Protein Inform on Potent Antagonist Activity Against Nicotinic Receptors

Overview

Journal Acta Crystallogr D Struct Biol

Specialty Biochemistry

Date 2022 Mar 2

PMID 35234149

Authors

Renata V Bueno

Samuel Davis

Alice Dawson

Pauline W Ondachi

F Ivy Carroll

William N Hunter

Affiliations

Soon will be listed here.

Abstract

Low-nanomolar binding constants were recorded for a series of six 2'-fluoro-(carbamoylpyridinyl)deschloroepibatidine analogues with acetylcholine-binding protein (AChBP). The crystal structures of three complexes with AChBP reveal details of molecular recognition in the orthosteric binding site and imply how the other three ligands bind. Comparisons exploiting AChBP as a surrogate for α4β2 and α7 nicotinic acetylcholine receptors (nAChRs) suggest that the key interactions are conserved. The ligands interact with the same residues as the archetypal nAChR agonist nicotine yet display greater affinity, thereby rationalizing their in vivo activity as potent antagonists of nicotine-induced antinociception. An oxyanion-binding site is formed on the periphery of the AChBP orthosteric site by Lys42, Asp94, Glu170 and Glu210. These residues are highly conserved in the human α4, β2 and α7 nAChR sequences. However, specific sequence differences are discussed that could contribute to nAChR subtype selectivity and in addition may represent a point of allosteric modulation. The ability to engage with this peripheral site may explain, in part, the function of a subset of ligands to act as agonists of α7 nAChR.

Citing Articles

Delineating the activity of the potent nicotinic acetylcholine receptor agonists (+)-anatoxin-a and (-)-hosieine-A.

Parker H, Dawson A, Jones M, Yan R, OuYang J, Hong R Acta Crystallogr F Struct Biol Commun. 2022; 78(Pt 9):313-323.

PMID: 36048081 PMC: 9435674. DOI: 10.1107/S2053230X22007762.

References

Ondachi P, Castro A, Luetje C, Wageman C, Marks M, Damaj M . Synthesis, Nicotinic Acetylcholine Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(carbamoylpyridinyl)deschloroepibatidine Analogues. ACS Chem Neurosci. 2016; 7(7):1004-12. DOI: 10.1021/acschemneuro.6b00107. View

Brams M, Pandya A, Kuzmin D, van Elk R, Krijnen L, Yakel J . A structural and mutagenic blueprint for molecular recognition of strychnine and d-tubocurarine by different cys-loop receptors. PLoS Biol. 2011; 9(3):e1001034. PMC: 3066128. DOI: 10.1371/journal.pbio.1001034. View

Coe J, Brooks P, Vetelino M, Wirtz M, Arnold E, Huang J . Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem. 2005; 48(10):3474-7. DOI: 10.1021/jm050069n. View

Dallanoce C, Matera C, De Amici M, Rizzi L, Pucci L, Gotti C . The enantiomers of epiboxidine and of two related analogs: synthesis and estimation of their binding affinity at α4β2 and α7 neuronal nicotinic acetylcholine receptors. Chirality. 2012; 24(7):543-51. DOI: 10.1002/chir.22052. View

Dawson A, Trumper P, Oliveira de Souza J, Parker H, Jones M, Hales T . Engineering a surrogate human heteromeric α/β glycine receptor orthosteric site exploiting the structural homology and stability of acetylcholine-binding protein. IUCrJ. 2019; 6(Pt 6):1014-1023. PMC: 6830221. DOI: 10.1107/S205225251901114X. View

Dineley K, Pandya A, Yakel J . Nicotinic ACh receptors as therapeutic targets in CNS disorders. Trends Pharmacol Sci. 2015; 36(2):96-108. PMC: 4324614. DOI: 10.1016/j.tips.2014.12.002. View

Carroll F . Epibatidine structure-activity relationships. Bioorg Med Chem Lett. 2004; 14(8):1889-96. DOI: 10.1016/j.bmcl.2004.02.007. View

daCosta C, Baenziger J . Gating of pentameric ligand-gated ion channels: structural insights and ambiguities. Structure. 2013; 21(8):1271-83. DOI: 10.1016/j.str.2013.06.019. View

Mu L, Drandarov K, Bisson W, Schibig A, Wirz C, Schubiger P . Synthesis and binding studies of epibatidine analogues as ligands for the nicotinic acetylcholine receptors. Eur J Med Chem. 2006; 41(5):640-50. DOI: 10.1016/j.ejmech.2006.01.015. View

10.

Fyfe P, Dawson A, Hutchison M, Cameron S, Hunter W . Structure of Staphylococcus aureus adenylosuccinate lyase (PurB) and assessment of its potential as a target for structure-based inhibitor discovery. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 8):881-8. PMC: 2917274. DOI: 10.1107/S0907444910020081. View

11.

Hansen S, Sulzenbacher G, Huxford T, Marchot P, Taylor P, Bourne Y . Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations. EMBO J. 2005; 24(20):3635-46. PMC: 1276711. DOI: 10.1038/sj.emboj.7600828. View

12.

Gotti C, Clementi F, Fornari A, Gaimarri A, Guiducci S, Manfredi I . Structural and functional diversity of native brain neuronal nicotinic receptors. Biochem Pharmacol. 2009; 78(7):703-11. DOI: 10.1016/j.bcp.2009.05.024. View

13.

Traynor J . Epibatidine and pain. Br J Anaesth. 1998; 81(1):69-76. DOI: 10.1093/bja/81.1.69. View

14.

Taly A, Corringer P, Guedin D, Lestage P, Changeux J . Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system. Nat Rev Drug Discov. 2009; 8(9):733-50. DOI: 10.1038/nrd2927. View

15.

Winn M, Ballard C, Cowtan K, Dodson E, Emsley P, Evans P . Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr. 2011; 67(Pt 4):235-42. PMC: 3069738. DOI: 10.1107/S0907444910045749. View

16.

Sauguet L, Shahsavar A, Delarue M . Crystallographic studies of pharmacological sites in pentameric ligand-gated ion channels. Biochim Biophys Acta. 2014; 1850(3):511-23. DOI: 10.1016/j.bbagen.2014.05.007. View

17.

Galzi J, Bertrand S, Corringer P, Changeux J, Bertrand D . Identification of calcium binding sites that regulate potentiation of a neuronal nicotinic acetylcholine receptor. EMBO J. 1996; 15(21):5824-32. PMC: 452330. View

18.

Murshudov G, Skubak P, Lebedev A, Pannu N, Steiner R, Nicholls R . REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D Biol Crystallogr. 2011; 67(Pt 4):355-67. PMC: 3069751. DOI: 10.1107/S0907444911001314. View

19.

Li S, Huang S, Bren N, Noridomi K, Dellisanti C, Sine S . Ligand-binding domain of an α7-nicotinic receptor chimera and its complex with agonist. Nat Neurosci. 2011; 14(10):1253-9. PMC: 3489043. DOI: 10.1038/nn.2908. View

20.

Celie P, van Rossum-Fikkert S, van Dijk W, Brejc K, Smit A, Sixma T . Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures. Neuron. 2004; 41(6):907-14. DOI: 10.1016/s0896-6273(04)00115-1. View